| Application no. and date | 21721092.1 (espacenet) (Federated) (European Patent Register), 20210426 | | Patent/reg. no. and date | DK/EP 4142770, 20260311 | | Publication date | 20230308 | | Priority no. and date | EP 20171536, 20200427, EP 20173341, 20200506 | | EP pub. no. and date |
EP 4142770 20230308 | | Effective date | | | Applicant/owner | Novo Nordisk A/S, Novo Allé, 2880 Bagsværd, DK | | Applicant ref. no. | | | Inventor | LINDER, Martin, 2880 Bagsværd, DK,
PALLE, Mads, Sundby, 2880 Bagsværd, DK,
DAMGAARD, Lars, Holm, 2880 Bagsværd, DK,
HANSEN, Morten, 2880 Bagsværd, DK,
TORSTENSON, Carl Richard, 2880 Bagsværd, DK | | Representative | | | Opponent | | | IPC Class | A61K 38/26 (2006.01) , A61P 1/16 (2006.01) | | Title | SEMAGLUTIDE FOR THE TREATMENT OF NON-ALCOHOLIC STEATOHEPATITIS | | Int. application no. | EP2021060827 | | Int. publication no. | WO2021219543 | | Related patent (certificate) | | | Status | Enhedspatent registreret | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
